Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.335 USD | +5.12% | -7.99% | -1.12% |
24/04 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
25/03 | North American Morning Briefing : Tech in Focus on -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.12% | 321M | |
+30.10% | 684B | |
+30.34% | 568B | |
-3.89% | 361B | |
+18.30% | 329B | |
+4.09% | 284B | |
+16.21% | 240B | |
+9.66% | 208B | |
-6.83% | 200B | |
+6.82% | 166B |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.
- Cantor Fitzgerald Starts Precigen at Overweight With $7 Price Target